Acyclovir

Product NDC
50090-1624
11-digit product format
500901624
Labeler code
50090
Product ID
50090-1624_576fa806-8b11-4c7e-815e-49bd39bfbfaf
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Acyclovir
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA203834
Marketing category
ANDA
Marketing start
2013-11-29
Marketing end
0000-00-00
Substance
ACYCLOVIR
Active strength
800 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-1624ACYCLOVIR TABLET [A-S MEDICATION SOLUTIONS]28Legacy NDC20250501_09b1adb0-945f-4008-b3df-44b467953209.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-1624-05009016240035 TABLET in 1 BOTTLE (50090-1624-0) 35 tablet2015-01-120000-00-00NoNoCurrent
50090-1624-25009016240270 TABLET in 1 BOTTLE (50090-1624-2) 70 tablet2015-01-120000-00-00NoNoCurrent
50090-1624-35009016240340 TABLET in 1 BOTTLE (50090-1624-3) 40 tablet2018-08-070000-00-00NoNoCurrent